Genetic reprogramming of bacterial biofilms

US9815871B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9815871-B2
Application numberUS-201414786304-A
CountryUS
Kind codeB2
Filing dateApr 23, 2014
Priority dateApr 23, 2013
Publication dateNov 14, 2017
Grant dateNov 14, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are methods and compositions relating to engineered curli fibers, e.g. CsgA polypeptide. In some embodiments, the methods and compositions described herein relate to functionalized biofilms.

First claim

Opening claim text (preview).

What is claimed herein is: 1. A functionalized engineered CsgA polypeptide comprising an activity polypeptide fused to a full-length Escherichia coli CsgA polypeptide by a flexible linker sequence; wherein the activity polypeptide comprises a conjugation domain; wherein the conjugation domain is specifically bound to a partner conjugation domain of a target polypeptide; wherein the target polypeptide comprises the partner conjugation domain fused to a functionalizing polypeptide; wherein the conjugation domain is selected from the group consisting of SpyTag, biotin acceptor peptide (BAP), biotin carboxyl carrier protein (BCCP), and a peptide comprising a LPXTG motif (SEQ ID NO: 23); wherein the partner conjugation domain is selected from the group consisting of SpyCatcher, streptavidin, and a peptide comprising aminoglycine; and wherein the flexible linker sequence comprises at least 6 amino acids. 2. The functionalized engineered CsgA polypeptide of claim 1 , wherein the flexible linker sequence consists of glycine and serine residues. 3. The functionalized engineered CsgA polypeptide of claim 1 , wherein the flexible linker sequence includes from 6 to 100 amino acids. 4. The functionalized engineered CsgA polypeptide of claim 1 , wherein the flexible linker sequence includes from 30 to 100 amino acids. 5. The functionalized engineered CsgA polypeptide of claim 1 , wherein the flexible linker sequence includes from 6 to 30 amino acids. 6. The functionalized engineered CsgA polypeptide of claim 1 , wherein the flexible linker sequence includes from 20 to 50 amino acids. 7. The functionalized engineered CsgA polypeptide of claim 1 , wherein the flexible linker sequence includes from 30 to 50 amino acids. 8. The functionalized engineered CsgA polypeptide of claim 1 , wherein the functionalizing polypeptide is an enzyme or an antibody. 9. The functionalized engineered CsgA polypeptide of claim 1 , wherein the conjugation domain or the functionalizing polypeptide further comprises an extracellular localization tag. 10. A biofilm including a functionalized engineered CsgA polypeptide comprising an activity polypeptide fused to a full length Escherichia coli CsgA polypeptide by a flexible linker sequence; wherein the activity polypeptide comprises a conjugation domain; wherein the conjugation domain is specifically bound to a partner conjugation domain of a target polypeptide; wherein the target polypeptide comprises the partner conjugation domain fused to a functionalizing polypeptide; wherein the conjugation domain is selected from the group consisting of SpyTag, biotin acceptor peptide (BAP), biotin carboxyl carrier protein (BCCP), and a peptide comprising a LPXTG motif (SEQ ID NO: 23); wherein the partner conjugation domain is selected from the group consisting of SpyCatcher, streptavidin, and a peptide comprising aminoglycine; and wherein the flexible linker sequence comprises at least 6 amino acids. 11. The functionalized engineered CsgA polypeptide of claim 1 , wherein the SpyTag comprises the amino acid sequence of SEQ ID NO: 9. 12. The biofilm of claim 10 , wherein the SpyTag comprises the amino acid sequence of SEQ ID NO: 9. 13. The biofilm of claim 10 , wherein the functionalizing polypeptide is an enzyme or an antibody. 14. A curli fiber comprising the functionalized engineered CsgA polypeptide of claim 1 . 15. A bacterial cell comprising the curli fiber of claim 14 .

Assignees

Inventors

Classifications

  • Antibacterial agents · CPC title

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • containing a domain for self-assembly, e.g. a viral coat protein (includes phage display) · CPC title

  • C07K14/245Primary

    Escherichia (G) · CPC title

  • containing a tag with affinity for a non-protein ligand · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9815871B2 cover?
Described herein are methods and compositions relating to engineered curli fibers, e.g. CsgA polypeptide. In some embodiments, the methods and compositions described herein relate to functionalized biofilms.
Who is the assignee on this patent?
Harvard College
What technology area does this patent fall under?
Primary CPC classification C07K14/245. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).